Hypoxia-Specific Drug Tirapazamine Does Not Abrogate Hypoxic Tumor Cells in Combination Therapy with Irinotecan and Methylselenocysteine in Well-Differentiated Human Head and Neck Squamous Cell Carcinoma A253 Xenografts

Well-differentiated hypoxic regions in head and neck squamous cell carcinoma like in A253 xenografts are avascular and, therefore, hinder drug delivery leading to drug resistance and tumor regrowth. Methylselenocysteine (MSC, 0.2 mg/mouse per day per oral for 35 days starting 7 days before the first...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bhattacharya, Arup, Tóth, Károly, Durrani, Farukh A, Cao, Shousong, Slocum, Harry K, Chintala, Sreenivasulu, Rustum, Youcef M
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Neoplasia Press Inc. 2008
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2481573/
https://ncbi.nlm.nih.gov/pubmed/18670644
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items